EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 71 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $230,000 | -3.8% | 34,379 | +22.8% | 0.01% | -25.0% |
| Q2 2021 | $239,000 | +58.3% | 27,999 | +63.8% | 0.01% | +33.3% |
| Q1 2021 | $151,000 | -51.0% | 17,095 | -54.8% | 0.01% | -68.4% |
| Q3 2020 | $308,000 | +163.2% | 37,848 | +209.7% | 0.02% | +137.5% |
| Q2 2020 | $117,000 | +39.3% | 12,220 | -1.5% | 0.01% | +14.3% |
| Q1 2020 | $84,000 | -82.0% | 12,400 | -73.0% | 0.01% | -89.7% |
| Q4 2018 | $466,000 | +91.8% | 45,863 | +130.0% | 0.07% | +223.8% |
| Q2 2018 | $243,000 | – | 19,944 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 694,232 | $8,532,000 | 5.82% |
| P.A.W. CAPITAL CORP | 400,000 | $4,916,000 | 4.34% |
| Telemetry Investments, L.L.C. | 128,848 | $1,584,000 | 2.68% |
| Trellus Management Company, LLC | 206,404 | $2,537,000 | 2.09% |
| KNOTT DAVID M | 295,035 | $3,626,000 | 1.64% |
| 683 Capital Management, LLC | 2,683,600 | $32,982,000 | 1.56% |
| INTERWEST VENTURE MANAGEMENT CO | 764,918 | $9,401,000 | 1.17% |
| TOWERVIEW LLC | 130,000 | $1,598,000 | 1.14% |
| Vivo Capital, LLC | 1,791,257 | $22,015,000 | 0.98% |
| Altium Capital Management LP | 197,500 | $2,427,000 | 0.91% |